F. Dans, Surveillance de la consommation des antibiotiques-Réseau ATB Raisin-Résultats 2012 / 2014 / Maladies infectieuses / Rapports et synthèses / Publications et outils / Accueil, ANNEXE, vol.3, 2016.

F. Ventes-de-médicaments-en, le rapport d'analyse de l'année 2013-CommuniquéANSM : Agence nationale de sécurité du médicament et des produits de santé, 2016.

, BEH n°12-13/2013 / 2013 / Archives / BEH-Bulletin épidémiologique hebdomadaire / Publications et outils / Accueil [Internet, 2016.

O. Lortholary, J. Gangneux, K. Sitbon, B. Lebeau, F. De-monbrison et al., Epidemiological trends in invasive aspergillosis in France: the SAIF network, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00680990

, Clin Microbiol Infect, vol.17, issue.12, pp.1882-1891, 2011.

D. Neofytos, D. Horn, E. Anaissie, W. Steinbach, A. Olyaei et al., Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry, Clin Infect Dis, vol.48, issue.3, pp.265-73, 2009.

, WHO | Antimicrobial resistance: global report on surveillance, 2014.

S. Bailly, D. Maubon, P. Fournier, H. Pelloux, C. Schwebel et al., Impact des antifongiques sur la résistance des principales espèces de Candida en réanimationEvolution et tendances sur 10 ans, Journal de Mycologie Médicale / Journal of Medical Mycology, vol.26, issue.2, p.6, 2016.

P. E. Verweij, A. Chowdhary, W. Melchers, and J. F. Meis, Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Clin Infect Dis, p.885, 2015.

Y. Nivoix, A. Launoy, P. Lutun, J. Moulin, P. Pang et al., Adherence to recommendations for the use of antifungal agents in a tertiary care hospital, J Antimicrob Chemother, vol.67, issue.10, pp.2506-2519, 2012.

P. Pavese, Z. Ouachi, J. Vittoz, B. Lebeau, L. Foroni et al., Revue de pertinence des prescriptions des nouveaux antifongiques systémiques dans un hôpital universitaire. Médecine et Maladies Infectieuses, vol.37, pp.223-231, 2007.

. Aspergillose-pulmonaire-invasive-en-hématologie-em|consulte, , 2016.

M. Cornet, L. Fleury, C. Maslo, J. Bernard, and G. Brücker, Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hôpitaux de Paris. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area, J Hosp Infect, vol.51, issue.4, pp.288-96, 2002.

D. Caillot, O. Casasnovas, A. Bernard, J. F. Couaillier, C. Durand et al., Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery, JCO, vol.15, issue.1, pp.139-186, 1997.

, Critères d'infections fongiques invasives, 2016.

, Conférence de consensus SFHH de mars, 2000.

O. A. Cornely, J. Maertens, D. J. Winston, J. Perfect, A. J. Ullmann et al., Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia, New England Journal of Medicine, vol.356, issue.4, pp.348-59, 2007.

J. Maertens, O. Marchetti, R. Herbrecht, O. A. Cornely, U. Flückiger et al., European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update, Bone Marrow Transplant, vol.46, issue.5, pp.709-727, 2011.

R. Herbrecht, D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene et al., Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis, New England Journal of Medicine, vol.347, issue.6, pp.408-423, 2002.

. Timm-7, European Confederation of Medical Mycology, 2015.

R. Hajdu, R. Thompson, J. G. Sundelof, B. A. Pelak, F. A. Bouffard et al., Preliminary animal pharmacokinetics of the parenteral antifungal agent, vol.872

, Antimicrob Agents Chemother, vol.41, issue.11, pp.2339-2383, 1997.

J. A. Stone, X. Xu, G. A. Winchell, P. J. Deutsch, P. G. Pearson et al., Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma, Antimicrob Agents Chemother, vol.48, issue.3, pp.815-838, 2004.

A. R. Jeans, S. J. Howard, Z. Al-nakeeb, J. Goodwin, L. Gregson et al., Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus fumigatus in an In Vitro Model of Invasive Pulmonary Aspergillosis, Antimicrob Agents Chemother, vol.56, issue.10, pp.5180-5185, 2012.

A. Espinel-ingroff, Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts, J Clin Microbiol, vol.36, issue.10, pp.2950-2956, 1998.

K. L. Oakley, C. B. Moore, and D. W. Denning, In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp, Antimicrob Agents Chemother, vol.42, issue.10, pp.2726-2756, 1998.

D. W. Denning, C. C. Kibbler, and R. A. Barnes, British Society for Medical Mycology. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections, Lancet Infect Dis, vol.3, issue.4, pp.230-270, 2003.

A. Manal and . Fattah, Revue de pertinence sur le bon usage des antifongiques à l'échelle d'une région française, 2013.

S. Raymond, T. Henon, F. Grenouillet, F. Legrand, M. Woronoff-lemsi et al., Audit clinique des prescriptions d'antifongiques systémiques couteux au centre hospitalier universitaire de Besançon. Médecine et Maladies Infectieuses, vol.39, pp.125-157, 2009.

L. Molloy, E. Mcgrath, R. Thomas, K. S. Kaye, and M. J. Rybak, Acceptance of Pharmacist-Driven Antimicrobial Stewardship Recommendations With Differing Levels of Physician Involvement in a Children's Hospital. Clin Pediatr (Phila), 2016.

C. D. Waters, B. J. Bitton, A. Torosyan, and K. P. Myers, Clinical Pharmacist Management of Bacteremia in a Community Hospital Emergency Department, Ann Pharmacother, 2017.

D. Caillot, J. Couaillier, A. Bernard, O. Casasnovas, D. W. Denning et al., Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia, JCO, vol.19, issue.1, pp.253-262, 2001.

T. Felton, P. F. Troke, and W. W. Hope, Tissue Penetration of Antifungal Agents, Clin Microbiol Rev, vol.27, issue.1, pp.68-88, 2014.

A. Pascual, T. Calandra, S. Bolay, T. Buclin, J. Bille et al., Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes, Clin Infect Dis, vol.46, issue.2, pp.201-212, 2008.

A. Pascual, C. Csajka, T. Buclin, S. Bolay, J. Bille et al., Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections, Clin Infect Dis, vol.55, issue.3, pp.381-90, 2012.

A. Hulin, E. Dailly, and C. L. Guellec, Niveau de preuve du suivi thérapeutique pharmacologique du voriconazole, Therapie, vol.66, issue.2, pp.109-123, 2011.

S. Scodavolpe, S. Quaranta, B. Lacarelle, and C. Solas, Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization, Annales de Biologie Clinique, vol.72, issue.4, pp.391-404, 2014.

N. Wood, K. Tan, L. Purkins, G. Layton, J. Hamlin et al., Effect of omeprazole on the steady-state pharmacokinetics of voriconazole, Br J Clin Pharmacol, vol.56, issue.1, pp.56-61, 2003.

K. L. Wallace, R. L. Filipek, L. Hoz, R. M. Williamson, and J. C. , Subtherapeutic voriconazole concentrations associated with concomitant dexamethasone: case report and review of the literature, J Clin Pharm Ther, vol.41, issue.4, pp.441-444, 2016.

,

M. Valerio, C. G. Rodriguez-gonzalez, P. Muñoz, B. Caliz, M. Sanjurjo et al., Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed, J Antimicrob Chemother, vol.69, issue.7, pp.1993-2002, 2014.

S. Alfandari, C. Berthon, and V. Coiteux, Antifungal stewardship: Implementation in a French teaching hospital. Médecine et Maladies Infectieuses, vol.44, pp.154-162, 2014.

, Impact de l'éducation et un programme de gérance antifongique pour candidoses dans un centre de soins tertiaires thaïlandais, 2017.

, Available from: /fr/documents/773c7033dcc91c33d4f1e7d1df31139829a2b78b

G. Chamilos, M. Luna, R. E. Lewis, G. P. Bodey, R. Chemaly et al., Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period, Haematologica, vol.91, issue.7, pp.986-995, 1989.

F. Persat, Sérologie aspergillaire, d'hier à aujourd'hui pour demain, Journal de Mycologie Médicale / Journal of Medical Mycology, vol.22, issue.1, pp.72-82, 2012.

S. Imbert, L. Gauthier, M. Palous, J. I. Loiseau, G. Gay et al., Performances de la PCR Aspergillus sur sérum pour le diagnostic des aspergilloses invasives, Journal de Mycologie Médicale / Journal of Medical Mycology, vol.25, issue.3, p.220, 2015.

M. Arvanitis, P. D. Ziakas, I. M. Zacharioudakis, F. N. Zervou, A. M. Caliendo et al., PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance, J Clin Microbiol, vol.52, issue.10, pp.3731-3773, 2014.

S. M. Zaki and D. W. Denning, Serious fungal infections in Egypt, Eur J Clin Microbiol Infect Dis, 2017.

R. Sabino, C. Verissímo, J. Brandão, C. Martins, D. Alves et al., Serious fungal infections in Portugal, Eur J Clin Microbiol Infect Dis, 2017.

M. Batac and D. Denning, Serious fungal infections in the Philippines, Eur J Clin Microbiol Infect Dis, 2017.

E. F. Nulens, M. J. Bourgeois, and M. B. Reynders, Post-influenza aspergillosis, do not underestimate influenza B. Infect Drug Resist, vol.10, pp.61-68, 2017.

J. Wauters, I. Baar, P. Meersseman, W. Meersseman, K. Dams et al., Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study, Intensive Care Med, vol.38, issue.11, pp.1761-1769, 2012.

A. Bergeron, R. Porcher, A. Sulahian, C. De-bazelaire, K. Chagnon et al., The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, issue.8, pp.1831-1837, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00818508

L. Fabien, Évaluation de la pertinence des prescriptions d'antifongiques au centre hospitalier universitaire de Grenoble, 2011.